healthcare policy
Commentary
Can Managed Access Agreements Mitigate Evidentiary, Economic and Ethical Issues with Access to Expensive Drugs for Rare Diseases in the Canadian Context?
Melanie McPhail and Tania Bubela
The Authors Respond
Expensive Drugs for Rare Diseases in Canada: Time for Action Everywhere and by Everyone
Sandra Sirrs, Helen Anderson, Bashir Jiwani, Eric Lun, Bob Nakagawa, Dean Regier, Shirin Rizzardo an...
Research Paper
Patent “Evergreening” of Medicine–Device Combination Products: A Global Perspective
Reed F. Beall, Tali Glazer, Haris Ahmad, Mikayla Buell, Slane Hahn, Adam R. Houston, Aaron S. Kessel...
Commentary
Virtual Care in Canada as of the Sixth Wave of the COVID-19 Pandemic: Finding the Right Balance – An Indigenous Perspective
Michael A.B. Anderson
The Author Responds
Response to Commentaries on Virtual Care as of the Sixth Wave of the COVID-19 Pandemic
William Falk
ICES Report
Dangerous “Toys”: The Burden of Non-Powdered Firearm Injuries in Canadian Children and Youth
Natasha Ruth Saunders, Misty Pratt and Charlotte Moore Hepburn